Translating Research Into Practice
Challenges in the Conduct of Research: Chemotherapy-Induced Peripheral Neuropathy
Constance Visovsky, PhD, RN, ACNP-BC
From University of South Florida College of Nursing, Tampa, Florida
The author has no conflicts of interest to disclose.
Correspondence to: Constance Visovsky, PhD, RN, ACNP-BC, University of South Florida, 12901 Bruce B. Downs Boulevard, MDC 22, Tampa, FL 33612-4766. E-mail: email@example.com
J Adv Pract Oncol 2013;4:369–371 |
DOI: 10.6004/jadpro.2013.4.5.9 |
© 2013 Harborside Press®
In a recent issue of JAMA, Smith et al. evaluated the use of duloxetine in the treatment of patients with painful chemotherapy-induced peripheral neuropathy (CIPN). Here, JADPRO contributors give an overview of the Smith study and offer a researcher’s perspective on the challenges associated with studying CIPN.
For access to the full length article, please sign in